Literature DB >> 3935041

Stress-induced neurological impairments in an animal model of parkinsonism.

A M Snyder, E M Stricker, M J Zigmond.   

Abstract

Adult rats were given the neurotoxin 6-hydroxydopamine (6-HDA) by means of cerebrospinal fluid to produce large dopamine-depleting brain lesions. Although the animals behaved normally in their home cages, they became akinetic after such treatments as glucoprivation, tail shock, and exposure to severe cold. The neurological impairments were related both to the extent of dopamine depletion and to the intensity of the stress. Drugs known to enhance dopaminergic function were found to reverse the stress-induced neurological deficits, while dopaminergic antagonists potentiated the debilitating effects of stress. After focal lesions were produced by injecting 6-hydroxydopamine directly into specific brain regions, stress-induced akinesia was found to correlate best with dopamine depletion in the corpus striatum, especially the lateral portion of that structure. These and other findings suggest that the acute emergence of parkinsonian symptoms during stress may reflect extensive damage to the dopaminergic nigrostriatal pathway that had been concealed in a preclinical phase, owing to compensatory neurochemical changes in the dopaminergic neurons that yet remain intact.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3935041     DOI: 10.1002/ana.410180506

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  18 in total

Review 1.  Stress, depression and Parkinson's disease.

Authors:  Ann M Hemmerle; James P Herman; Kim B Seroogy
Journal:  Exp Neurol       Date:  2011-10-06       Impact factor: 5.330

Review 2.  Neurobiology of aversive states.

Authors:  Erin N Umberg; Emmanuel N Pothos
Journal:  Physiol Behav       Date:  2011-05-01

Review 3.  Diagnosis and treatment of Parkinson's disease in the elderly.

Authors:  J I Sage; M H Mark
Journal:  J Gen Intern Med       Date:  1994-10       Impact factor: 5.128

4.  Acute Restraint Stress Augments 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine Neurotoxicity via Increased Toxin Uptake into the Brain in C57BL/6 Mice.

Authors:  Yasuhide Mitsumoto; Atsushi Mori
Journal:  Neurosci Bull       Date:  2018-07-09       Impact factor: 5.203

5.  Comparison of the Effects of COVID-19 Pandemic on Male and Female Gender in Patients Diagnosed with Idiopathic Parkinson's Disease: A Case of Sakarya Province, Turkey.

Authors:  Yeşim Güzey Aras; Belma Doğan Güngen; Türkan Acar; Bilgehan A Acar; Sena Boncuk; Halil A Eryilmaz
Journal:  Noro Psikiyatr Ars       Date:  2022-08-19       Impact factor: 1.066

6.  Rotenone-induced energy stress decompensated in ventral mesocerebrum is associated with Parkinsonism progression in rats.

Authors:  Qunhua Bai; Junlin He; Yong Tang; Shibo Wang; Jingfu Qiu; Yang Wang; Chao Yu
Journal:  Exp Ther Med       Date:  2016-05-18       Impact factor: 2.447

7.  Transient supression by stress of haloperidol induced catalepsy by the activation of the adrenal medulla.

Authors:  O P Yntema; J Korf
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

8.  Stress accelerates neural degeneration and exaggerates motor symptoms in a rat model of Parkinson's disease.

Authors:  Lori K Smith; Nafisa M Jadavji; Keri L Colwell; S Katrina Perehudoff; Gerlinde A Metz
Journal:  Eur J Neurosci       Date:  2008-04       Impact factor: 3.386

9.  Glucose utilization rates regulate intake levels of artificial sweeteners.

Authors:  Luis A Tellez; Xueying Ren; Wenfei Han; Sara Medina; Jozélia G Ferreira; Catherine W Yeckel; Ivan E de Araujo
Journal:  J Physiol       Date:  2013-09-23       Impact factor: 5.182

10.  A Case of early onset Parkinson's disease after major stress.

Authors:  Ke Zou; Wanjun Guo; Gongshun Tang; Bo Zheng; Zhong Zheng
Journal:  Neuropsychiatr Dis Treat       Date:  2013-08-02       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.